Globe and Mail
by Sheryl Ubelacker

Taking high-dose folic acid during pregnancy does not prevent pre-eclampsia in women at elevated risk for the potentially deadly condition, a Canadian-led international study has found…Dr. Linda Szymanski, a maternal-fetal medicine specialist at the Mayo Clinic, said she was not surprised by the finding and that high-dose folic acid is not something she or her colleagues would have prescribed to prevent pre-eclampsia. “I would hope if that people were prescribing it for pre-eclampsia prevention that this study would change their practice because it is a well-done randomized controlled trial, with a lot of subjects,” Szymanski, who was not involved in the research, said Wednesday from Rochester, Minn. “I think that if I were prescribing it for pre-eclampsia, this would have affected my practice.”

Reach: The Globe and Mail is Canada’s national newspaper and has a daily circulation of more than 316,000 and a weekend circulation of more than 369.000. The Globe and Mail Online has more than 11.8 million unique visitors to its website each month.

Additional coverage: CTV, CBC News, Yahoo! Canada, Ottawa Citizen, Vancouver Sun, Toronto Star, Calgary Herald, National Post, Winnipeg Free Press, Halifax Today

Context: Linda Szymanski, MD. is a Mayo Clinic maternal-fetal medicine specialist. Mayo Clinic has one of the largest and most respected obstetrics and gynecology practices in the world, with more than 55 specialists committed to providing comprehensive, multidisciplinary medical and surgical care to women at its campuses in Arizona, Florida and Minnesota. Mayo Clinic Health System locations serve more than 60 communities in Iowa, Minnesota and Wisconsin. These sites bring Mayo Clinic obstetrics and gynecology care to their local communities.

Contacts:  Sharon Theimer, Kelley Luckstein

Tags: Dr. Linda Szymanski, Globe and Mail, maternal fetal medicine, obstetrics and gynecology, Uncategorized